Soliton Selects RESONIC as Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
Scott R. Miller, MD, FACS, examines how commodification threatens plastic surgery’s emphasis on judgment and craft—and makes the case for a low-volume, high-quality approach to patient care.